-
1
-
-
0003243071
-
HIV prevalence in the United States, 2000
-
Paper presented at: February 25, Seattle, Wash
-
Fleming P, Byers RH, Sweeney PA, Daniels D, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. Paper presented at: 9th Conference on Retroviruses and Opportunistic Infections; February 25, 2002; Seattle, Wash.
-
(2002)
9th Conference on Retroviruses and Opportunistic Infections
-
-
Fleming, P.1
Byers, R.H.2
Sweeney, P.A.3
Daniels, D.4
Karon, J.M.5
Janssen, R.S.6
-
2
-
-
0038662597
-
Advancing HIV prevention: New strategies for a changing epidemic-United States, 2003
-
Janssen RS, Onorato IM, Valdiserri RO, et al. Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;52:329-332.
-
(2004)
MMWR Morb Mortal Wkly Rep
, vol.52
, pp. 329-332
-
-
Janssen, R.S.1
Onorato, I.M.2
Valdiserri, R.O.3
-
3
-
-
20444381790
-
-
Centers for Disease Control and Prevention, Atlanta, Ga: US Dept of Health and Human Services;
-
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003. Atlanta, Ga: US Dept of Health and Human Services; 2004.
-
(2004)
HIV/AIDS Surveillance Report, 2003
-
-
-
4
-
-
0031934113
-
HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities
-
Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998;88:108-113.
-
(1998)
Am J Public Health
, vol.88
, pp. 108-113
-
-
Kral, A.H.1
Bluthenthal, R.N.2
Booth, R.E.3
Watters, J.K.4
-
5
-
-
33846056050
-
-
Division of HIV/AIDS Prevention Centers for Disease Control and Prevention, Available at:, Accessed July 15
-
Division of HIV/AIDS Prevention Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic. Available at: http://www.cdc.gov/hiv/partners/AHP-brochure.htm. Accessed July 15, 2005.
-
(2005)
Advancing HIV Prevention: New Strategies for a Changing Epidemic
-
-
-
6
-
-
0033932171
-
HIV testing among the general US population and persons at increased risk: Information from national surveys, 1987-1996
-
Anderson JE, Carey JW, Taveras S. HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996. Am J Public Health. 2000;90:1089-1095.
-
(2000)
Am J Public Health
, vol.90
, pp. 1089-1095
-
-
Anderson, J.E.1
Carey, J.W.2
Taveras, S.3
-
7
-
-
33846083806
-
-
HIV Testing Survey, 5. Atlanta, Ga: Centers for Disease Control and Prevention;
-
HIV Testing Survey. HIV/AIDS Special Surveillance Report 5. Atlanta, Ga: Centers for Disease Control and Prevention; 2002.
-
(2002)
HIV/AIDS Special Surveillance Report
-
-
-
8
-
-
0036800553
-
HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing
-
Kellerman SE, Lehman JS, Lansky A, et al. HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr. 2002;31:202-210.
-
(2002)
J Acquir Immune Defic Syndr
, vol.31
, pp. 202-210
-
-
Kellerman, S.E.1
Lehman, J.S.2
Lansky, A.3
-
9
-
-
22344444456
-
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs
-
Marks G, Crepaz N, Senterfritt W, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453.
-
(2005)
J Acquir Immune Defic Syndr
, vol.39
, pp. 446-453
-
-
Marks, G.1
Crepaz, N.2
Senterfritt, W.3
Janssen, R.S.4
-
10
-
-
13444267665
-
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy
-
Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New Engl J Med. 2005;352:570-585.
-
(2005)
New Engl J Med
, vol.352
, pp. 570-585
-
-
Sanders, G.D.1
Bayoumi, A.M.2
Sundaram, V.3
-
11
-
-
13444270732
-
Expanded screening for HIV in the United States-an analysis of cost-effectiveness
-
Paltiel AD, Weinstein MC, Rimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. New Engl J Med. 2005;352:586-595.
-
(2005)
New Engl J Med
, vol.352
, pp. 586-595
-
-
Paltiel, A.D.1
Weinstein, M.C.2
Rimmel, A.D.3
-
12
-
-
13444256367
-
Routine screening for HIV infection-timely and cost-effective
-
Bozzette SA. Routine screening for HIV infection-timely and cost-effective. New Engl J Med. 2005;352:620-621.
-
(2005)
New Engl J Med
, vol.352
, pp. 620-621
-
-
Bozzette, S.A.1
-
13
-
-
21544461760
-
Screening for HIV: Recommendation statement
-
US Preventive Services Task Force
-
US Preventive Services Task Force. Screening for HIV: recommendation statement. Ann Intern Med. 2005;143:32-37.
-
(2005)
Ann Intern Med
, vol.143
, pp. 32-37
-
-
-
14
-
-
0036792621
-
Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities
-
Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 2002;97:1277-1287.
-
(2002)
Addiction
, vol.97
, pp. 1277-1287
-
-
Heimer, R.1
Clair, S.2
Grau, L.E.3
Bluthenthal, R.N.4
Marshall, P.A.5
Singer, M.6
-
15
-
-
4544310799
-
Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities
-
Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall PA, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99:1136-1146.
-
(2004)
Addiction
, vol.99
, pp. 1136-1146
-
-
Bluthenthal, R.N.1
Malik, M.R.2
Grau, L.E.3
Singer, M.4
Marshall, P.A.5
Heimer, R.6
-
16
-
-
0036955172
-
Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut 1990-2001
-
Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut 1990-2001. J Urban Health. 2002;79:556-570.
-
(2002)
J Urban Health
, vol.79
, pp. 556-570
-
-
Heimer, R.1
Clair, S.2
Teng, W.3
Grau, L.E.4
Khoshnood, K.5
Singer, M.6
-
17
-
-
0142182394
-
Neighborhood differences in patterns of syringe access use, and discard among injection drug users: Implications for HIV outreach and prevention education
-
Buchanan D, Shaw S, Teng W, Hiser P, Singer M. Neighborhood differences in patterns of syringe access use, and discard among injection drug users: implications for HIV outreach and prevention education. J Urban Health. 2003;80:438-454.
-
(2003)
J Urban Health
, vol.80
, pp. 438-454
-
-
Buchanan, D.1
Shaw, S.2
Teng, W.3
Hiser, P.4
Singer, M.5
-
18
-
-
22744452200
-
Lessons from the field: From research to application in the fight against AIDS among injection drug users in three New England cities
-
Singer M, Stopka T, Shaw S, et al. Lessons from the field: from research to application in the fight against AIDS among injection drug users in three New England cities. Hum Organ. 2005;64:179-191.
-
(2005)
Hum Organ
, vol.64
, pp. 179-191
-
-
Singer, M.1
Stopka, T.2
Shaw, S.3
-
19
-
-
0004239560
-
-
National Institute on Drug Abuse, Rockville, MD: National Institutes of Health, Dept of Health and Human Services;
-
National Institute on Drug Abuse. Risk Behavior Assessment. Rockville, MD: National Institutes of Health, Dept of Health and Human Services; 1991.
-
(1991)
Risk Behavior Assessment
-
-
-
20
-
-
0025061894
-
The limitations of the concept of needle sharing: The practice of frontloading
-
Grund JP, Kaplan CD, Adriaans NF, Blanken P, Huisman J. The limitations of the concept of needle sharing: the practice of frontloading. AIDS. 1990;4:819-821.
-
(1990)
AIDS
, vol.4
, pp. 819-821
-
-
Grund, J.P.1
Kaplan, C.D.2
Adriaans, N.F.3
Blanken, P.4
Huisman, J.5
-
21
-
-
17644424289
-
Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention
-
Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005;9:27-39.
-
(2005)
AIDS Behav
, vol.9
, pp. 27-39
-
-
Koester, S.1
Glanz, J.2
Baron, A.3
-
22
-
-
0028915770
-
HIV sero-prevalence in injection drug users
-
Watters JK, Bluthenthal RN, Kral AH. HIV sero-prevalence in injection drug users. JAMA. 1995;273:1178.
-
(1995)
JAMA
, vol.273
, pp. 1178
-
-
Watters, J.K.1
Bluthenthal, R.N.2
Kral, A.H.3
-
23
-
-
0034272442
-
Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS)
-
Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr. 2000;25:63-70.
-
(2000)
J Acquir Immune Defic Syndr
, vol.25
, pp. 63-70
-
-
Monterroso, E.R.1
Hamburger, M.E.2
Vlahov, D.3
-
24
-
-
4344633903
-
Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users
-
Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377-400.
-
(2004)
J Urban Health
, vol.81
, pp. 377-400
-
-
Friedman, S.R.1
Tempalski, B.2
Cooper, H.3
-
25
-
-
0033819765
-
Factors associated with HIV testing and returning for test results in a sample of out-of-treatment drug users
-
Ziek K, Goldstein MF, Beardsley M, Deren S, Tortu S. Factors associated with HIV testing and returning for test results in a sample of out-of-treatment drug users. J Drug Issues. 2000;30:675-686.
-
(2000)
J Drug Issues
, vol.30
, pp. 675-686
-
-
Ziek, K.1
Goldstein, M.F.2
Beardsley, M.3
Deren, S.4
Tortu, S.5
-
27
-
-
0038217089
-
Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998
-
Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidermiol. 2003;157:915-922.
-
(2003)
Am J Epidermiol
, vol.157
, pp. 915-922
-
-
Kral, A.H.1
Lorvick, J.2
Gee, L.3
-
28
-
-
0034671622
-
Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996
-
Quellet LJ, Thorpe LE, Huo D, et al. Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996. J Acquir Immune Defic Syndr. 2000;25:443-450.
-
(2000)
J Acquir Immune Defic Syndr
, vol.25
, pp. 443-450
-
-
Quellet, L.J.1
Thorpe, L.E.2
Huo, D.3
-
29
-
-
0036784787
-
Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998
-
Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156:641-653.
-
(2002)
Am J Epidemiol
, vol.156
, pp. 641-653
-
-
Nelson, K.E.1
Galai, N.2
Safaeian, M.3
Strathdee, S.A.4
Celentano, D.D.5
Vlahov, D.6
-
30
-
-
0037372517
-
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
-
Des Jarlais DC, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157:467-471.
-
(2003)
Am J Epidemiol
, vol.157
, pp. 467-471
-
-
Des Jarlais, D.C.1
Diaz, T.2
Perlis, T.3
-
31
-
-
0028980674
-
HIV incidence among New Haven needle exchange participants: Updated estimates from syringe tracking and testing data
-
Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:175-176.
-
(1995)
J Acquir Immune Defic Syndr Hum Retrovirol
, vol.10
, pp. 175-176
-
-
Kaplan, E.H.1
Heimer, R.2
-
32
-
-
2942546614
-
Prevalence and incidence of HW, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons
-
Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HW, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218-1223.
-
(2004)
Am J Public Health
, vol.94
, pp. 1218-1223
-
-
Macalino, G.E.1
Vlahov, D.2
Sanford-Colby, S.3
-
33
-
-
0035313574
-
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study
-
Seage GR III, Holte SE, Metzger D, et al. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol 2001;153:619-627.
-
(2001)
Am J Epidemiol
, vol.153
, pp. 619-627
-
-
Seage III, G.R.1
Holte, S.E.2
Metzger, D.3
-
34
-
-
23044510831
-
HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services
-
Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
-
(2005)
Am J Public Health
, vol.95
, pp. 1439-1444
-
-
Des Jarlais, D.C.1
Perlis, T.2
Arasteh, K.3
-
35
-
-
0031690149
-
Correlates of HIV seropositivity and HIV testing among out-of-treatment drug users
-
Collier K, Kotranski L, Semaan S, Lauby J, Halbert J, Feighan K. Correlates of HIV seropositivity and HIV testing among out-of-treatment drug users. Am J Drug Alcohol Abuse. 1998;24:377-393.
-
(1998)
Am J Drug Alcohol Abuse
, vol.24
, pp. 377-393
-
-
Collier, K.1
Kotranski, L.2
Semaan, S.3
Lauby, J.4
Halbert, J.5
Feighan, K.6
-
36
-
-
5444253787
-
Correlates of HIV antibody testing among a sample of injection drug users: The role of social and contextual factors
-
Tobin KE, Tang AM, Gilbert SH, Latkin CA. Correlates of HIV antibody testing among a sample of injection drug users: the role of social and contextual factors. AIDS Behav. 2004;8:303-310.
-
(2004)
AIDS Behav
, vol.8
, pp. 303-310
-
-
Tobin, K.E.1
Tang, A.M.2
Gilbert, S.H.3
Latkin, C.A.4
-
37
-
-
0035237279
-
I don't know when it might pop up: Understanding repeat HIV testing and perceptions of HIV among drug users
-
Vernon KA, Mulia N, Downing M, Knight K, Riess T. "I don't know when it might pop up": understanding repeat HIV testing and perceptions of HIV among drug users. J Subst Abuse. 2001;13:215-227.
-
(2001)
J Subst Abuse
, vol.13
, pp. 215-227
-
-
Vernon, K.A.1
Mulia, N.2
Downing, M.3
Knight, K.4
Riess, T.5
-
38
-
-
0035670019
-
Motives for HIV testing among drug users: An analysis of gender differences
-
Riess TH, Kim C, Downing M. Motives for HIV testing among drug users: an analysis of gender differences. AIDS Educ Prev. 2001;13:509-523.
-
(2001)
AIDS Educ Prev
, vol.13
, pp. 509-523
-
-
Riess, T.H.1
Kim, C.2
Downing, M.3
-
39
-
-
0030817514
-
Gender differences and other factors associated with HIV testing in a national sample of active drug injectors
-
Davis WR, Deren S, Beardsley M, Wenston J, Tortu S. Gender differences and other factors associated with HIV testing in a national sample of active drug injectors. AIDS Educ Prev. 1997;9:342-358.
-
(1997)
AIDS Educ Prev
, vol.9
, pp. 342-358
-
-
Davis, W.R.1
Deren, S.2
Beardsley, M.3
Wenston, J.4
Tortu, S.5
-
40
-
-
0030449772
-
Utilization of HIV antibody testing by out-of-treatment drug users
-
Liebman J, Brooks D, Bonilla L, Kotranski L. Utilization of HIV antibody testing by out-of-treatment drug users. J Drug Issues. 1996;26:679-693.
-
(1996)
J Drug Issues
, vol.26
, pp. 679-693
-
-
Liebman, J.1
Brooks, D.2
Bonilla, L.3
Kotranski, L.4
-
41
-
-
24344453273
-
Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: A study of rapid versus standard testing
-
Wurcel A, Zaman T, Zhen S, Stone D. Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: a study of rapid versus standard testing. AIDS Patient Care STDS. 2005;19:499-505.
-
(2005)
AIDS Patient Care STDS
, vol.19
, pp. 499-505
-
-
Wurcel, A.1
Zaman, T.2
Zhen, S.3
Stone, D.4
-
42
-
-
14744305811
-
Choosing HIV counseling and testing strategies for outreach settings: A randomized trial
-
Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. J Acquir Immune Defic Syndr. 2005;38:348-355.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 348-355
-
-
Spielberg, F.1
Branson, B.M.2
Goldbaum, G.M.3
-
43
-
-
32544454166
-
Supplemental testing for confirmation of reactive oral fluid rapid HIV antibody tests
-
Anonymous
-
Anonymous. Supplemental testing for confirmation of reactive oral fluid rapid HIV antibody tests. MMWR [dispatch]. 2005;54:1287-1288.
-
(2005)
MMWR [dispatch]
, vol.54
, pp. 1287-1288
-
-
-
45
-
-
0035330078
-
Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999)
-
Thorpe LE, Bailey SL, Huo D, Monterroso ER, Quellet LJ. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J Acquir Immune Defic Syndr. 2001;27:71-78.
-
(2001)
J Acquir Immune Defic Syndr
, vol.27
, pp. 71-78
-
-
Thorpe, L.E.1
Bailey, S.L.2
Huo, D.3
Monterroso, E.R.4
Quellet, L.J.5
-
46
-
-
9144238059
-
Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001
-
Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr. 2004;35:158-166.
-
(2004)
J Acquir Immune Defic Syndr
, vol.35
, pp. 158-166
-
-
Des Jarlais, D.C.1
Perlis, T.2
Arasteh, K.3
-
47
-
-
33846110888
-
Syringe exchange, community coverage, declining AIDS rates
-
Paper presented at: June 13, Atlanta, Ga
-
Heimer R, Khoshnood K, Buchanan D, et al. Syringe exchange, community coverage, declining AIDS rates. Paper presented at: 2005 National HIV Prevention Conference; June 13, 2005; Atlanta, Ga.
-
(2005)
2005 National HIV Prevention Conference
-
-
Heimer, R.1
Khoshnood, K.2
Buchanan, D.3
-
48
-
-
0030978971
-
Needle exchange is not enough: Lessons from the Vancouver injecting drug use study
-
Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59-F65.
-
(1997)
AIDS
, vol.11
-
-
Strathdee, S.A.1
Patrick, D.M.2
Currie, S.L.3
-
49
-
-
0038708362
-
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
-
Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887-893.
-
(2003)
AIDS
, vol.17
, pp. 887-893
-
-
Tyndall, M.W.1
Currie, S.2
Spittal, P.3
-
50
-
-
33846070151
-
-
HIV-infection Information Bulletin No. 1 [in Russian]. Russian Federal AIDS Center; 1994. In: Gardner KJ. HIV Testing and the Law in Russia; 1996. Available at: http://www.openweb.ru/aesop/eng/hiv-hr/hiv. html. Accessed May 25, 2005.
-
"HIV-infection" Information Bulletin No. 1 [in Russian]. Russian Federal AIDS Center; 1994. In: Gardner KJ. HIV Testing and the Law in Russia; 1996. Available at: http://www.openweb.ru/aesop/eng/hiv-hr/hiv. html. Accessed May 25, 2005.
-
-
-
-
51
-
-
1442315993
-
HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation
-
Rhodes T, Sarang A, Bobrik A, Bobkov A, Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy. 2004;15:1-16.
-
(2004)
Int J Drug Policy
, vol.15
, pp. 1-16
-
-
Rhodes, T.1
Sarang, A.2
Bobrik, A.3
Bobkov, A.4
Platt, L.5
-
52
-
-
0004291545
-
-
National Institutes of Health Consensus Development Program, Bethesda, Md: National Institutes of Health;, Report 104
-
National Institutes of Health Consensus Development Program. Interventions to prevent HIV risk behaviors. Bethesda, Md: National Institutes of Health; 1997. Report 104.
-
(1997)
Interventions to prevent HIV risk behaviors
-
-
-
53
-
-
0032125142
-
Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States
-
Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1)5133-5138.
-
(1998)
J Acquir Immune Defic Syndr Hum Retrovirol
, vol.18
, Issue.SUPPL. 1
, pp. 5133-5138
-
-
Holtgrave, D.R.1
Pinkerton, S.D.2
Jones, T.S.3
Lurie, P.4
Vlahov, D.5
-
54
-
-
33846106824
-
Impact and cost-effectiveness of methadone maintenance programs for HIV and hepatitis C prevention
-
Weissing L, ed, Utrecht Netherlands: European Monitoring Centre for Drugs and Drug Addiction;
-
Pollack HA, Heimer R. Impact and cost-effectiveness of methadone maintenance programs for HIV and hepatitis C prevention. In: Weissing L, ed. Impact and Costs of Hepatitis C in Injecting Drug Users in the European Union. Utrecht Netherlands: European Monitoring Centre for Drugs and Drug Addiction; 2003.
-
(2003)
Impact and Costs of Hepatitis C in Injecting Drug Users in the European Union
-
-
Pollack, H.A.1
Heimer, R.2
-
55
-
-
1442291565
-
Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world
-
Wood E, Montaner JS, Bangsberg DR, et al. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS. 2003;17:2419-2427.
-
(2003)
AIDS
, vol.17
, pp. 2419-2427
-
-
Wood, E.1
Montaner, J.S.2
Bangsberg, D.R.3
-
56
-
-
0142151386
-
Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users
-
Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health, 2003;30:416-427.
-
(2003)
J Urban Health
, vol.30
, pp. 416-427
-
-
Altice, F.L.1
Springer, S.2
Buitrago, M.3
Hunt, D.P.4
Friedland, G.H.5
-
57
-
-
2942530602
-
Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication
-
Altice FL, Mezger JA, Hodges J, et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis. 2004;38(suppl 5):S376-S387.
-
(2004)
Clin Infect Dis
, vol.38
, Issue.SUPPL. 5
-
-
Altice, F.L.1
Mezger, J.A.2
Hodges, J.3
-
58
-
-
19544379027
-
Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodefiniciency virus infection
-
Vlahov D, Galai N, Safaeian M, et al. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodefiniciency virus infection. Am J Epidemiol. 2005;161:999-1012.
-
(2005)
Am J Epidemiol
, vol.161
, pp. 999-1012
-
-
Vlahov, D.1
Galai, N.2
Safaeian, M.3
-
59
-
-
4444227111
-
Mortality in HIV-seropositive versus seronegative persons in the era of highly active antiretroviral therapy: Implications for when to initiate therapy
-
Wang C, Vlahov D, Galai N, et al. Mortality in HIV-seropositive versus seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis. 2004;190:1046-1054.
-
(2004)
J Infect Dis
, vol.190
, pp. 1046-1054
-
-
Wang, C.1
Vlahov, D.2
Galai, N.3
|